pk 11195 has been researched along with Basal Ganglia Diseases in 1 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henkel, K | 1 |
| Karitzky, J | 1 |
| Schmid, M | 1 |
| Mader, I | 1 |
| Glatting, G | 1 |
| Unger, JW | 1 |
| Neumaier, B | 1 |
| Ludolph, AC | 1 |
| Reske, SN | 1 |
| Landwehrmeyer, GB | 1 |
1 other study available for pk 11195 and Basal Ganglia Diseases
| Article | Year |
|---|---|
Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration.
Topics: Aged; Basal Ganglia Diseases; Cerebral Cortex; Functional Laterality; Humans; Isoquinolines; Magneti | 2004 |